NAS10027,087+1.72%S&P7,401+0.65%GOLD$4,073−1.00%BTC$75,828−0.15%VIX24.55−12.88%latest tape · as of 20:03 UTC
The Screen · Industrials · Specialty Industrial Machinery
Crane Co
CR · the NYSE · USD · Market cap $10.6B · 9,000 employees
Crane Company, together with its subsidiaries, engages in the manufacture and sale of engineered industrial products in the United States, Canada, the United Kingdom, Continental Europe, and internationally.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 12.06, read 2026-11-05
Ethical passes the values gate
Price197.79 USD
Fair value198.86
Ethical score70.0/100
Value readFairas of 5 Nov 2026
Our investment reviews on this name
2026-10-25Read Distribution182.89+8.1% to today Accumulation gives way to Distribution
2026-10-24Read Accumulation182.89+8.1% to today ✓Markdown gives way to Accumulation after an 11% slide in 2 days
2026-10-22Read Markdown205.73-3.9% to today ✓Accumulation gives way to Markdown
2026-10-02Read Accumulation198.96-0.6% to today Distribution gives way to Accumulation after a 9% slide in 5 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Crane Co holds its Markup at $197.79. The statistical read favours the sellers, held for 6 days.
As held on the ledger · 2026-11-05
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 6 days
Price at the screen
$197.79
Valuation
31.92 trailing · 23.34 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.07
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
31.56%
Below 33%
Interest-bearing debt is just 31.6% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
22.45%
Below 49%
Money owed to the company is 22.5% of assets, under the 49% limit.
Pass
Revenue purity
0.49%
Below 5%
Only 0.5% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Crane Co clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 32%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CR's ethical verdict changes
Today CR passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 5 Nov 2026: it trades at roughly a 0% discount to our $198.86 fair value, narrow competitive moat, 25.60% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 0.5% discount to the base estimate.
Third-party analyst targets: 10 covering, consensus Strong Buy. The average target sits +22% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Where our models see it going: fair-value estimate $198.86, with a range of $172.80 to $228.68, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Crane pays up for steady industrial kit
Picture a factory floor where every valve and actuator must survive brutal conditions. Crane builds those components across aerospace and industrial markets, posting 25% revenue growth and a 13% profit margin while earning a 17% return on equity. The narrow moat and clean ethical screen are real, yet none of that offsets the gap between the current price and our fair value.
At 28.5 times forward earnings the shares sit 13% above fair value with an opportunity rating of none. Strong analyst targets around 225 do not change the arithmetic. Paying a premium multiple for a narrow-moat industrial name leaves little room for the ordinary setbacks that hit this sector.
Cyclical exposure means earnings can peak just when multiples compress. Investors chasing the growth number risk anchoring to high-water marks that later prove fleeting. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CR trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-03Distribution$204.04+11.6%Entry 16
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 11.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (9 analysts) rates it strong buy, with a mean price target of $220.
2026-10-27Distribution$182.89+0.0%Entry 15
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (9 analysts) rates it strong buy, with a mean price target of $220. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Distribution$182.89+0.0%Entry 14
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (9 analysts) rates it strong buy, with a mean price target of $220. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (9 analysts) rates it strong buy, with a mean price target of $220. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 11.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (9 analysts) rates it strong buy, with a mean price target of $220. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markdown$205.73+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (9 analysts) rates it strong buy, with a mean price target of $220. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markdown · changed$205.73+0.0%Entry 10
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (9 analysts) rates it strong buy, with a mean price target of $220. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Accumulation$205.73+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (9 analysts) rates it strong buy, with a mean price target of $220. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Accumulation$205.73+0.5%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (9 analysts) rates it strong buy, with a mean price target of $220. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Accumulation$204.75+2.9%Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (9 analysts) rates it strong buy, with a mean price target of $220.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
